Consolidated balance sheet

          Dec. 31, 2013 Dec. 31, 2012
      Note   DKK million DKK million
               
    ASSETS          
               
    Intangible assets 2.1, 4.1   2,864  2,672 
    Property, plant and equipment 2.1, 4.2   7,135  7,084 
    Deferred tax assets   4.6   456  224 
    Other financial assets   5.2   14    -
    Investment in associate   4.4   45  52 
    Other receivables   3.3   162  191 
    Non-current assets       10,676  10,223 
               
    Inventories   3.1   1,902  1,808 
    Trade receivables   3.2   2,242  2,080 
    Tax receivables   4.6   151  138 
    Other receivables   3.3   301  284 
    Other financial assets 5.2, 5.3   87  45 
    Cash at bank and in hand   6.8   1,003  535 
            5,686  4,890 
               
    Assets held for sale   4.7   144    -
    Current assets       5,830  4,890 
               
    Assets       16,506  15,113 
               
               
    LIABILITIES AND SHAREHOLDERS' EQUITY          
               
    Common stock   6.6   639  650 
    Other reserves       169  432 
    Retained earnings       10,246  8,473 
    Equity attributable to shareholders in Novozymes A/S       11,054  9,555 
    Non-controlling interests       12  13 
    Shareholders' equity       11,066  9,568 
               
    Deferred tax liabilities   4.6   956  741 
    Provisions   4.3   151  140 
    Other financial liabilities   5.2   1,734  1,749 
    Non-current liabilities       2,841  2,630 
               
    Provisions   4.3   128  90 
    Other financial liabilities 5.2, 5.3   105  286 
    Trade payables       976  1,044 
    Tax payables   4.6   356  371 
    Other liabilities   3.4   1,034  1,124 
    Current liabilities       2,599  2,915 
               
    Liabilities       5,440  5,545 
               
    Liabilities and shareholders' equity       16,506  15,113